Invention Grant
- Patent Title: Treatment of cognitive and mood symptoms in neurodegenerative and neuropsychiatric disorders with Alpha5-containing GABA
-
Application No.: US17122745Application Date: 2020-12-15
-
Publication No.: US11753412B2Publication Date: 2023-09-12
- Inventor: James M. Cook , Guanguan Li , Michael Ming-Jin Poe , Miroslav M. Savic , Etienne Sibille
- Applicant: UWM Research Foundation, Inc. , Centre for Addiction and Mental Health , University of Belgrade—Faculty of Pharmacy
- Applicant Address: US WI Milwaukee
- Assignee: UWM Research Foundation, Inc.,Centre for Addiction and Mental Health,University of Belgrade—Faculty of Pharmacy
- Current Assignee: UWM Research Foundation, Inc.,Centre for Addiction and Mental Health,University of Belgrade—Faculty of Pharmacy
- Current Assignee Address: US WI Milwaukee; CA Toronto; RS Belgrade
- Agency: Michael Best & Friedrich LLP
- Main IPC: C07D487/04
- IPC: C07D487/04 ; A61K31/5517 ; A61P25/00 ; A61P25/18 ; A61P25/22 ; A61P25/24 ; A61P25/28
Abstract:
Provided herein are alpha5-containing GABAA receptor agonists and pharmaceutical compositions and methods of treatment of cognitive and mood symptoms in neurodegenerative and neuropsychiatric disorders using them.
Public/Granted literature
Information query
